| MeSH term | MeSH ID | Detail |
|---|---|---|
| Glomerulonephritis, Membranous | D015433 | 6 associated lipids |
| Weight Loss | D015431 | 56 associated lipids |
| Weight Gain | D015430 | 101 associated lipids |
| Myocardial Reperfusion Injury | D015428 | 20 associated lipids |
| Reperfusion Injury | D015427 | 65 associated lipids |
| Zellweger Syndrome | D015211 | 39 associated lipids |
| Wounds and Injuries | D014947 | 20 associated lipids |
| Weil Disease | D014895 | 2 associated lipids |
| Granulomatosis with Polyangiitis | D014890 | 5 associated lipids |
| Vitamin E Deficiency | D014811 | 29 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Feuerstein G | Eicosanoids in deteriorating stroke. Review of studies on the rabbit spinal cord ischemia and reperfusion model. | 1989 | Ann. N. Y. Acad. Sci. | pmid:2774403 |
| Panganamala RV and Cornwell DG | The effects of vitamin E on arachidonic acid metabolism. | 1982 | Ann. N. Y. Acad. Sci. | pmid:6816121 |
| Hansen TN and Carpenter JF | The role of platelets in chilling-induced injury. | 1994 | Ann. N. Y. Acad. Sci. | pmid:8017779 |
| Numano F et al. | Prostacyclin and variant angina. | 1985 | Ann. N. Y. Acad. Sci. | pmid:3865605 |
| Hartung HP et al. | Substance P stimulates release of arachidonic acid cyclooxygenation products from primary culture rat astrocytes. | 1988 | Ann. N. Y. Acad. Sci. | pmid:2462817 |
| Takami M et al. | Effect of DP-1904, a new thromboxane A2 synthetase inhibitor, on guinea pig experimental asthma. | 1991 | Ann. N. Y. Acad. Sci. | pmid:1952565 |
| Crinnion JN et al. | Neutrophils and the endothelium in post-ischemic alterations in skeletal muscle blood flow. | 1994 | Ann. N. Y. Acad. Sci. | pmid:8030907 |
| Elmadfa I et al. | Influence of a single parenteral application of a 10% fish oil emulsion on plasma fatty acid pattern and the function of thrombocytes in young adult men. | 1993 | Ann. Nutr. Metab. | pmid:8470873 |
| Cunnane SC | Vitamin E intake affects serum thromboxane and tissue essential fatty acid composition in the rat. | 1988 | Ann. Nutr. Metab. | pmid:3214140 |
| Quoc KP and Pascaud M | Effects of dietary gamma-linolenic acid on the tissue phospholipid fatty acid composition and the synthesis of eicosanoids in rats. | 1996 | Ann. Nutr. Metab. | pmid:8773734 |
| Masi I et al. | Diets rich in saturated, monounsaturated and polyunsaturated fatty acids differently affect plasma lipids, platelet and arterial wall eicosanoids in rabbits. | 1986 | Ann. Nutr. Metab. | pmid:3513691 |
| Ferry DR et al. | A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints. | 2000 | Ann. Oncol. | pmid:11061613 |
| Diven WF et al. | Expression of acute otitis media after receptor blockade of platelet activating factor, thromboxane, and leukotrienes in the chinchilla. | 1998 | Ann. Otol. Rhinol. Laryngol. | pmid:9525240 |
| Herrick AL et al. | Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis. | 1996 | Ann. Rheum. Dis. | pmid:8712862 |
| Tishler M et al. | Salivary eicosanoid concentration in patients with Sjögren's syndrome. | 1996 | Ann. Rheum. Dis. | pmid:8712887 |
| Katz JM et al. | Inhibition of prostaglandin action and bone resorption by copper. | 1984 | Ann. Rheum. Dis. | pmid:6441529 |
| Tsai CY et al. | Effect of antibodies to double stranded DNA, purified from serum samples of patients with active systemic lupus erythematosus, on the glomerular mesangial cells. | 1992 | Ann. Rheum. Dis. | pmid:1550397 |
| Salmon JA et al. | Synthesis of arachidonate cyclo-oxygenase products by rheumatoid and nonrheumatoid synovial lining in nonproliferative organ culture. | 1983 | Ann. Rheum. Dis. | pmid:6402992 |
| Seitz M and Hunstein W | Enhanced prostanoid release from monocytes of patients with rheumatoid arthritis and active systemic lupus erythematosus. | 1985 | Ann. Rheum. Dis. | pmid:4026405 |
| Doube A et al. | Effect of misoprostol on concentrations of prostaglandins in synovial fluid. | 1991 | Ann. Rheum. Dis. | pmid:1772296 |
| Taha AS et al. | Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis. | 1990 | Ann. Rheum. Dis. | pmid:2143369 |
| Welbourn R et al. | Involvement of thromboxane and neutrophils in multiple-system organ edema with interleukin-2. | 1990 | Ann. Surg. | pmid:2256765 |
| Fletcher JR et al. | Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia. | 1990 | Ann. Surg. | pmid:2178565 |
| Anner H et al. | Pulmonary hypertension and leukosequestration after lower torso ischemia. | 1987 | Ann. Surg. | pmid:3675025 |
| Klausner JM et al. | The rapid induction by interleukin-2 of pulmonary microvascular permeability. | 1989 | Ann. Surg. | pmid:2783363 |
| Huval WV et al. | Role of serotonin in patients with acute respiratory failure. | 1984 | Ann. Surg. | pmid:6547816 |
| Utsunomiya T et al. | Maintenance of cardiodynamics with aspirin during abdominal aortic aneurysmectomy (AAA). | 1981 | Ann. Surg. | pmid:6117260 |
| Mackey WC et al. | Aspirin decreases platelet uptake on Dacron vascular grafts in baboons. | 1984 | Ann. Surg. | pmid:6233945 |
| Myers SI et al. | Reperfusion inhibits elevated splanchnic prostanoid production after hemorrhagic shock. | 1990 | Ann. Surg. | pmid:2256760 |
| Paterson IS et al. | Pulmonary edema after aneurysm surgery is modified by mannitol. | 1989 | Ann. Surg. | pmid:2511812 |
| Klausner JM et al. | Limb ischemia-induced increase in permeability is mediated by leukocytes and leukotrienes. | 1988 | Ann. Surg. | pmid:3196098 |
| Klausner JM et al. | Lower torso ischemia-induced lung injury is leukocyte dependent. | 1988 | Ann. Surg. | pmid:3196099 |
| Fletcher JR et al. | Tumor necrosis factor-induced mortality is reversed with cyclooxygenase inhibition. | 1993 | Ann. Surg. | pmid:8507112 |
| Valeri CR et al. | Hypothermia-induced reversible platelet dysfunction. | 1987 | Ann. Surg. | pmid:3813688 |
| Rivkind AI et al. | Sequential patterns of eicosanoid, platelet, and neutrophil interactions in the evolution of the fulminant post-traumatic adult respiratory distress syndrome. | 1989 | Ann. Surg. | pmid:2549891 |
| Klausner JM et al. | Vasodilating prostaglandins attenuate ischemic renal injury only if thromboxane is inhibited. | 1989 | Ann. Surg. | pmid:2644899 |
| Gottlieb A et al. | The role of prostacyclin in the mesenteric traction syndrome during anesthesia for abdominal aortic reconstructive surgery. | 1989 | Ann. Surg. | pmid:2647052 |
| Lelcuk S et al. | Thromboxane A2 moderates permeability after limb ischemia. | 1985 | Ann. Surg. | pmid:3840349 |
| Welbourn R et al. | Interleukin-2 induces early multisystem organ edema mediated by neutrophils. | 1991 | Ann. Surg. | pmid:1867524 |
| Li G et al. | Cardiac ischemic preconditioning improves lung preservation in valve replacement operations. | 2001 | Ann. Thorac. Surg. | pmid:11235719 |
| Schönberger JP et al. | Systemic blood activation with open and closed venous reservoirs. | 1995 | Ann. Thorac. Surg. | pmid:7771838 |
| Shafique T et al. | Cardiopulmonary bypass and pulmonary thromboxane generation. | 1993 | Ann. Thorac. Surg. | pmid:8452438 |
| Karwande SV et al. | Effect of preoperative antiplatelet drugs on vascular prostacyclin synthesis. | 1987 | Ann. Thorac. Surg. | pmid:3548616 |
| DeCampli WM et al. | Pharmacological, hematological, and physiological effects of a new thromboxane synthetase inhibitor (CGS-13080) during cardiopulmonary bypass in dogs. | 1986 | Ann. Thorac. Surg. | pmid:3789860 |
| Sunose Y et al. | Effect of a cyclooxygenase-2 inhibitor, FK3311, in a canine lung transplantation model. | 2001 | Ann. Thorac. Surg. | pmid:11603431 |
| Mainwaring RD et al. | Complement activation and cytokine generation after modified Fontan procedure. | 1998 | Ann. Thorac. Surg. | pmid:9647087 |
| Singh HP et al. | Prostacyclin and thromboxane levels in pleural space fluid during cardiopulmonary bypass. | 1995 | Ann. Thorac. Surg. | pmid:7887705 |
| Lappegård KT et al. | Differential effect of heparin coating and complement inhibition on artificial surface-induced eicosanoid production. | 2005 | Ann. Thorac. Surg. | pmid:15734405 |
| Teoh KH et al. | Blood conservation with membrane oxygenators and dipyridamole. | 1987 | Ann. Thorac. Surg. | pmid:3300583 |
| Hashimoto K et al. | Perfusion pressure control by adenosine triphosphate given during cardiopulmonary bypass. | 1993 | Ann. Thorac. Surg. | pmid:8417658 |